Overview

Chutian Technology Co., Ltd. was established in 2000 and has become one of the leading enterprises in the global pharmaceutical equipment industry. The company specializes in pharmaceutical equipment and integrated technology solutions, and is a pioneer in the research and development of intelligent pharmaceutical factories. It is a publicly traded company listed on the A-share market in China. Chutian Technology has several wholly-owned or majority-owned subsidiaries, including Germany's ROMACO Group, Chutian Huaxing, Sichuan Pharmaceutical Design Institute, Chutian Feiyun, Chutian Yuanchuang, Chutian Huaxing, and Chutian Intelligent Robotics. The company employs a total of 6,500 people globally and has total assets exceeding 8 billion RMB. The company has two main operational headquarters located in Changsha and Germany, and has established three major R&D institutions: the Central Technology Research Institute in Changsha, the European Technology Research Institute, and the Sichuan Pharmaceutical Design Research Institute. It also has several technology and innovation platforms, including a national enterprise technology center, a national innovation base, a postdoctoral research workstation, and an academician expert workstation. As of October 30, 2021, Chutian has filed 3,816 Chinese patent applications, with 2,307 valid patents. Additionally, 35 PCT international patent applications have been filed, with 19 patents granted in countries including the U.S., Russia, India, South Korea, Germany, Indonesia, and Europe. The company has led the development of 17 national industry product technical standards for its systems. Chutian’s products have been exported to over 40 countries and regions in Asia, Europe, and South America, with its international market share rapidly increasing each year. In addition to maintaining its established business areas, Chutian plans to enter the high-end medical equipment and medical robotics fields, promoting the dual development of pharmaceutical equipment and medical devices, and expanding into the broader health sector. The company upholds its core values of "Being a Respected Person, Creating Respected Products, and Operating a Respected Enterprise," and promotes the spirit of "Excellence through Persistence." Its business purpose focuses on "Customer-Centricity, Supporting the Diligent, and Results-Oriented Goal Responsibility," with a mission to "Equip the Global Pharmaceutical Industry with Intelligence." Chutian aims to become one of the global leaders in the pharmaceutical equipment industry by around 2030.